mTOR signalling has been described as implicated in tumour development, metastasis, and drug resistance [28, 29]; thus, mTOR targeting successfully inhibits tumour growth and renders them sensitive to conventional treatments [30, 31]. Here, MTOR is linked to neoplasm.